In vitro effect of C2-C18 fatty acids on Salmonellas
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
15227798
DOI
10.1007/bf02931402
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents chemistry pharmacology MeSH
- Time Factors MeSH
- Adaptation, Physiological MeSH
- Glucose metabolism MeSH
- Caprylates pharmacology MeSH
- Hydrogen-Ion Concentration MeSH
- Fatty Acids chemistry pharmacology MeSH
- Microbial Sensitivity Tests MeSH
- Colony Count, Microbial MeSH
- Salmonella enteritidis drug effects growth & development metabolism MeSH
- Salmonella typhimurium drug effects growth & development metabolism MeSH
- Salmonella drug effects growth & development metabolism MeSH
- Drug Tolerance MeSH
- Calcium pharmacology MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
- Glucose MeSH
- Caprylates MeSH
- Fatty Acids MeSH
- octanoic acid MeSH Browser
- Calcium MeSH
The susceptibility of Salmonella spp. to 15 fatty acids was determined in vitro in cultures grown on glucose. Antimicrobial activity was expressed as IC50 (a concentration at which only 50% of the initial glucose in cultures was utilized). Caprylic acid was the only acid inhibiting glucose utilization. In cultures of S. enteritidis, S. infantis and S. typhimurium, IC50 of caprylic acid ranged from 0.75 to 1.17 mg/mL. A moderate adaptation effect was observed as these values increased 1.5-1.8 times when bacteria were subcultured 10 times in media containing a low concentration of caprylic acid (1/3 IC50). No effect of calcium ions added in excess on antimicrobial activity of caprylic acid was observed. Incubation of salmonellas with caprylic acid (1 mg/mL; 30 min) at pH 5.2-5.3 led to a reduction in the concentration of viable cells below the detection limit; 2-6% of Salmonella cells survived at pH 6.3-6.6.
See more in PubMed
J Food Prot. 2000 Sep;63(9):1282-6 PubMed
J Nutr. 1999 Jul;129(7):1382-9 PubMed
J Appl Bacteriol. 1973 Dec;36(4):659-75 PubMed
J Hyg (Lond). 1979 Apr;82(2):263-83 PubMed
Int J Antimicrob Agents. 2002 Oct;20(4):258-62 PubMed
J Appl Bacteriol. 1971 Dec;34(4):803-13 PubMed
Appl Environ Microbiol. 2001 Apr;67(4):1979-82 PubMed
Zentralbl Veterinarmed B. 1980;27(8):631-9 PubMed
Reprod Nutr Dev. 1995;35(4):353-65 PubMed
Folia Microbiol (Praha). 2003;48(6):731-5 PubMed
Avian Dis. 1992 Jan-Mar;36(1):139-42 PubMed
Antimicrob Agents Chemother. 1972 Jul;2(1):23-8 PubMed
Oral application of Enterococcus faecium strain EE3 in healthy dogs